Catalyst
Slingshot members are tracking this event:
ZIOPHARM (ZIOP) to launch Phase 1 trial in patients with glioblastoma using the combination of Ad-RTS-IL-12 + veledimex and a selected checkpoint inhibitor in 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ZIOP |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 27, 2016
Occurred Source:
http://ir.ziopharm.com/releasedetail.cfm?ReleaseID=977245
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1 Trial, Glioblastoma, Ad-rts-hil-12, Veledimex, Checkpoint Inhibitor
